Chimerism Analysis Is Predictive of Relapse-Free Survival After Allogeneic Transplantation for MDS

被引：0
|
作者：
Mohan, Sanjay R. [1 ]
Rybicki, Lisa [1 ]
Kalaycio, Matt [1 ]
Sobecks, Ronald [1 ]
Bolwell, Brian J. [1 ]
Copelan, Edward A. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：571 / 571
页数：1
相关论文
共 50 条
  • [21] THE REVISED IPSS (IPSS-R) AT TRANSPLANT PREDICTS OVERALL AND RELAPSE-FREE SURVIVAL AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN MDS/SAML: A RETROSPECTIVE ANALYSIS OF THE EBMT CHRONIC MALIGNANCIES WORKING PARTY
    Scheid, C.
    de Wreede, L.
    van Biezen, A.
    Goehring, G.
    Koenecke, C.
    Volin, L.
    Maertens, J.
    Finke, J.
    Schaap, N.
    Socie, G.
    Passweg, J.
    Cornelissen, J.
    Beelen, D.
    de Witte, T.
    Kroeger, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S93 - S94
  • [22] The Revised IPSS (IPSS-R) At Transplant Predicts Overall and Relapse-Free Survival After Allogeneic Stem Cell Transplantation In MDS/sAML: A Retrospective Analysis Of The EBMT Chronic Malignancies Working Party
    Scheid, Christof
    de Wreede, Liesbeth
    van Biezen, Anja
    Goehring, Gudrun
    Koenecke, Christian
    Violin, Liisa
    Maertens, Johan
    Finke, Juergen
    Schaap, Nicolaas P. M.
    Passweg, Jakob
    Socie, Gerard
    Beelen, Dietrich
    Cornelissen, Jan
    de Witte, Theo M.
    Kroeger, Nikolaus
    BLOOD, 2013, 122 (21)
  • [23] Factors Predicting GVHD-Free, Relapse-Free Survival (GRFS) after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia; Multi Variable Analysis of 190 Patients
    Abu Shanap, M.
    Rihani, R.
    Hashem, H.
    Khattab, E.
    Tbakhi, A.
    Sultan, I.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S307 - S307
  • [24] Prognostic Factors on the Graft-versus-Host Disease-Free and Relapse-Free Survival after Adult Allogeneic Hematopoietic Stem Cell Transplantation
    Liu, Yao-Chung
    Chien, Sheng-Hsuan
    Fan, Nai-Wen
    Hu, Ming-Hung
    Gau, Jyh-Pyng
    Liu, Chia-Jen
    Yu, Yuan-Bin
    Hsiao, Liang-Tsai
    Chiou, Tzeon-Jye
    Tzeng, Cheng-Hwai
    Chen, Po-Min
    Liu, Jin-Hwang
    STEM CELLS INTERNATIONAL, 2016, 2016
  • [25] The predictive value of T-cell chimerism for disease relapse after allogeneic hematopoietic stem cell transplantation
    Li, Zhipeng
    Wang, Jing
    Deng, Lei
    Liu, Ximin
    Kong, Fanjun
    Zhao, Yuerong
    Hou, Yixi
    Zhou, Fang
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [26] Factors Predicting Graft-versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Cell Transplantation: Multivariable Analysis from a Single Center
    Solh, Melhem
    Zhang, Xu
    Connor, Katelin
    Brown, Stacey
    Solomon, Scott R.
    Morris, Lawrence E.
    Holland, H. Kent
    Bashey, Asad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (08) : 1403 - 1409
  • [27] Analysis of chimerism for detecting relapse or graft failure after allogeneic hematopoietic stem cell transplantation
    Kasai, M
    Nakagawa, M
    Ohnishi, S
    Kobayashi, N
    Ogasawara, M
    Kiyama, Y
    Naohara, T
    Higa, T
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 207 - 207
  • [28] Capecitabine after surgery significantly increases relapse-free survival
    不详
    ONCOLOGY-NEW YORK, 2004, 18 (08): : 1077 - 1078
  • [29] Improved relapse-free survival in melanoma
    不详
    EUROPEAN JOURNAL OF CANCER, 2007, 43 (13) : 1887 - 1887
  • [30] Determinants of refined GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies
    Jindra, Pavel
    Karas, Michal
    Lysak, Daniel
    Sramek, Jiri
    Steinerova, Katerina
    Hrabetova, Marcela
    Jungova, Alexandra
    LEUKEMIA RESEARCH, 2023, 127
12345